Publications by authors named "Dean Boyall"

Claim this Profile
D
Discovery of Selective, Orally Bioavailable Pyrazolopyridine Inhibitors of Protein Kinase Cθ (PKCθ) That Ameliorate Symptoms of Experimental Autoimmune Encephalomyelitis.
Philip N Collier, Heather C Twin, Ronald M A Knegtel, Dean Boyall, Guy Brenchley

ACS Med Chem Lett· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New 4-Amino-1,2,3-Triazole Inhibitors of Indoleamine 2,3-Dioxygenase Form a Long-Lived Complex with the Enzyme and Display Exquisite Cellular Potency.
Julie Anne Christine Alexandre, Michael Kenneth Swan, Mike John Latchem, Dean Boyall, John Robert Pollard

Chembiochem· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design and optimization of selective protein kinase C θ (PKCθ) inhibitors for the treatment of autoimmune diseases.
Juan-Miguel Jimenez, Dean Boyall, Guy Brenchley, Philip N Collier, Christopher J Davis

J Med Chem· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structure-based optimization of aminopyridines as PKCθ inhibitors.
Juan-Miguel Jimenez, Christopher Davis, Dean Boyall, Damien Fraysse, Ronald Knegtel

Bioorg Med Chem Lett· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diastereoselective zinc-catalyzed conjugate addition of alkynes.
Thomas F Knöpfel, Dean Boyall, Erick M Carreira

Org Lett· June 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficient enantioselective additions of terminal alkynes and aldehydes under operationally convenient conditions.
Dean Boyall, Doug E Frantz, Erick M Carreira

Org Lett· July 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis